ABVC BioPharma completes $2.28M additional unregistered offering, issues 1.5M shares

ABVC BIOPHARMA, INC.

From May 26, 2025 to Jan 6, 2026, ABVC accepted additional subscriptions totaling $2,275,468 under same terms as prior Reg S offering.
Issued 1,500,250 shares of common stock at prices ranging from $1.00 to $1.95 per share.
Shares represent approximately 5.92% of outstanding common stock as of filing date.
All purchasers are non-U.S. persons (accredited investors); voting rights transferred to Chairman Eugene Jiang via proxy agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.